Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2013 1
2015 1
2021 4
2022 2
2023 3
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial.
Schlaich MP, Bellet M, Weber MA, Danaietash P, Bakris GL, Flack JM, Dreier RF, Sassi-Sayadi M, Haskell LP, Narkiewicz K, Wang JG; PRECISION investigators. Schlaich MP, et al. Lancet. 2022 Dec 3;400(10367):1927-1937. doi: 10.1016/S0140-6736(22)02034-7. Epub 2022 Nov 7. Lancet. 2022. PMID: 36356632 Clinical Trial.
Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction: The SOCRATES-REDUCED Randomized Trial.
Gheorghiade M, Greene SJ, Butler J, Filippatos G, Lam CS, Maggioni AP, Ponikowski P, Shah SJ, Solomon SD, Kraigher-Krainer E, Samano ET, Müller K, Roessig L, Pieske B; SOCRATES-REDUCED Investigators and Coordinators. Gheorghiade M, et al. JAMA. 2015 Dec 1;314(21):2251-62. doi: 10.1001/jama.2015.15734. JAMA. 2015. PMID: 26547357 Clinical Trial.
Risks and benefits of renal artery stenting in fibromuscular dysplasia: Lessons from the ARCADIA-POL study.
Kądziela J, Jóźwik-Plebanek K, Pappaccogli M, van der Niepen P, Prejbisz A, Dobrowolski P, Michałowska I, Talarowska P, Warchoł-Celińska E, Stryczyński Ł, Krekora J, Andziak P, Szczerbo-Trojanowska M, Maciąg R, Sterliński I, Witkowski A, Januszewicz A, Adlam D, Januszewicz M, Persu A. Kądziela J, et al. Among authors: krekora j. Vasc Med. 2024 Feb;29(1):50-57. doi: 10.1177/1358863X231210523. Epub 2023 Dec 12. Vasc Med. 2024. PMID: 38084723
Prediction of major adverse cardiac events in patients with multivessel coronary artery disease with an interpretable classification tree model based on coronary computed tomography angiography.
Kaczmarek D, Matuszewska-Brycht O, Kobierecki M, Jakuszczonek M, Krekora J, Drożdż J. Kaczmarek D, et al. Among authors: krekora j. Kardiol Pol. 2023;81(12):1265-1268. doi: 10.33963/v.kp.98352. Kardiol Pol. 2023. PMID: 38189507 Free article. No abstract available.
Optimal medical therapy in patients with stable coronary artery disease in Poland: the ISCHEMIA trial experience.
Pracoń R, Demkow M, Anthopolos R, Mazurek T, Drożdż J, Witkowski A, Gajos G, Pruszczyk P, Roik M, Łoboz-Grudzień K, Lesiak M, Reczuch K, Kalarus Z, Kryczka K, Henzel J, Kaczmarska-Dyrda E, Maksym J, Jonik S, Krekora J, Celińska-Spodar M, Jaroch J, Łanocha M, Szulik M, Szwed H, Rużyłło W. Pracoń R, et al. Among authors: krekora j. Pol Arch Intern Med. 2021 Nov 30;131(11):16100. doi: 10.20452/pamw.16100. Epub 2021 Sep 29. Pol Arch Intern Med. 2021. PMID: 34585554 Free article. Clinical Trial.
Burden of multimorbidity in a Polish cohort of ambulatory and hospitalized heart failure patients from 2 large European registry programs: prognostic implications.
Sierpiński R, Franczuk P, Tkaczyszyn M, Suchocki T, Krekora J, Opolski G, Maggioni A, Poloński L, Ponikowski P, Jankowska EA. Sierpiński R, et al. Among authors: krekora j. Pol Arch Intern Med. 2021 Nov 30;131(11):16101. doi: 10.20452/pamw.16101. Epub 2021 Sep 29. Pol Arch Intern Med. 2021. PMID: 34585879 Free article.
12 results